HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Plan For Spending Comparative Effectiveness Money Due July 30

This article was originally published in The Tan Sheet

Executive Summary

Questions swirling around the $1.1 billion in comparative effectiveness research funding should be answered by July 30, the due date for a report to Congress with details of how the money provided in the economic stimulus package for the research will be spent

You may also be interested in...



Patient Library Needed For Comparative Research Findings – Experts

A centralized, user-friendly repository of outcomes is needed to ensure consumers and doctors can understand the increasing volume of comparative effectiveness research expected in coming years, policy experts suggest in Health Affairs.

Goodman Continues On Rising Star Arc As FDA’s Chief Medical Officer

Jesse Goodman has become FDA's acting chief medical officer and is the agency's lone representtative on the Federal Coordinating Committee on Comparative Effectiveness Research

Baucus Maintains Public/Private Comparative Effectiveness Vision

Senate Finance Committee Chairman Max Baucus continues planning to include comparative effectiveness in the health care reform debate, even with research funding included in the American Recovery and Reinvestment Act

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS136485

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel